These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7677997)

  • 41. Interference with HIV-1 reverse transcriptase-catalyzed DNA chain elongation by the 5'-triphosphate of the carbocyclic analog of 2'-deoxyguanosine.
    Parker WB; White EL; Shaddix SC; Ross LJ; Shannon WM; Secrist JA
    Antiviral Res; 1992 Oct; 19(4):325-32. PubMed ID: 1281392
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Functional analysis of primers and templates in the synthesis of DNA catalyzed by human immunodeficiency virus type 1 reverse transcriptase.
    Nevinsky GA; Andreola ML; Jamkovoy VI; Levina AS; Barr PJ; Tarrago-Litvak L; Tharaud D; Litvak S
    Eur J Biochem; 1992 Jul; 207(1):351-8. PubMed ID: 1378404
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kinetic interaction of human immunodeficiency virus type 1 reverse transcriptase with the antiviral tetrahydroimidazo[4,5,1-jk]-[1,4]-benzodiazepine-2-(1H)-thione compound, R82150.
    Frank KB; Noll GJ; Connell EV; Sim IS
    J Biol Chem; 1991 Aug; 266(22):14232-6. PubMed ID: 1713579
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition mechanisms of HIV-1, Mo-MuLV and AMV reverse transcriptases by Kelletinin A from Buccinulum corneum.
    Orlando P; Strazzullo G; Carretta F; De Falco M; Grippo P
    Experientia; 1996 Aug; 52(8):812-7. PubMed ID: 8774754
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synergistic inhibition of HIV-1 reverse transcriptase DNA polymerase activity and virus replication in vitro by combinations of carboxanilide nonnucleoside compounds.
    Fletcher RS; Arion D; Borkow G; Wainberg MA; Dmitrienko GI; Parniak MA
    Biochemistry; 1995 Aug; 34(32):10106-12. PubMed ID: 7543775
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro enzymatic activity of human immunodeficiency virus type 1 reverse transcriptase mutants in the highly conserved YMDD amino acid motif correlates with the infectious potential of the proviral genome.
    Wakefield JK; Jablonski SA; Morrow CD
    J Virol; 1992 Nov; 66(11):6806-12. PubMed ID: 1383571
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Column-switching high-performance liquid chromatographic determination of a 2-pyridinone-based human immunodeficiency virus type 1 (HIV-1)-specific reverse transcriptase inhibitor in human plasma.
    Woolf EJ; Matuszewski BK
    Pharm Res; 1993 Jan; 10(1):56-60. PubMed ID: 7679213
    [TBL] [Abstract][Full Text] [Related]  

  • 48. p66/p51 and p51/p51 recombinant forms of reverse transcriptase from human immunodeficiency virus type 1--interactions with primer tRNA(Lys3), initiation of cDNA synthesis, and effect of inhibitors.
    Dufour E; El Dirani-Diab R; Boulmé F; Fournier M; Nevinsky G; Tarrago-Litvak L; Litvak S; Andreola ML
    Eur J Biochem; 1998 Jan; 251(1-2):487-95. PubMed ID: 9492322
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kinetic studies with the non-nucleoside HIV-1 reverse transcriptase inhibitor U-88204E.
    Althaus IW; Chou JJ; Gonzales AJ; Deibel MR; Chou KC; Kezdy FJ; Romero DL; Palmer JR; Thomas RC; Aristoff PA
    Biochemistry; 1993 Jul; 32(26):6548-54. PubMed ID: 7687145
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selective action of 4'-azidothymidine triphosphate on reverse transcriptase of human immunodeficiency virus type 1 and human DNA polymerases alpha and beta.
    Chen MS; Suttmann RT; Papp E; Cannon PD; McRoberts MJ; Bach C; Copeland WC; Wang TS
    Biochemistry; 1993 Jun; 32(23):6002-10. PubMed ID: 7685186
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of HIV-1 reverse transcriptase by 5'-triphosphates of 5-substituted uridine analogs.
    Tao PZ; Johansson NG; Stening G; Oberg B; Datema R
    Antiviral Res; 1989 Dec; 12(5-6):269-78. PubMed ID: 2483878
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and evaluation of 2-pyridinone derivatives as specific HIV-1 reverse transcriptase inhibitors. 3. Pyridyl and phenyl analogs of 3-aminopyridin-2(1H)-one.
    Wai JS; Williams TM; Bamberger DL; Fisher TE; Hoffman JM; Hudcosky RJ; MacTough SC; Rooney CS; Saari WS; Thomas CM
    J Med Chem; 1993 Jan; 36(2):249-55. PubMed ID: 7678654
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 3'-Azido-3',5'-dideoxythymidine-5'-methylphosphonic acid diphosphate: synthesis and HIV-1 reverse transcriptase inhibition.
    Freeman GA; Rideout JL; Miller WH; Reardon JE
    J Med Chem; 1992 Aug; 35(17):3192-6. PubMed ID: 1380561
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interaction of the reverse transcriptase of human immunodeficiency virus type 1 with DNA.
    Bakhanashvili M; Hizi A
    Biochemistry; 1994 Oct; 33(40):12222-8. PubMed ID: 7522556
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The benzylthio-pyrimidine U-31,355, a potent inhibitor of HIV-1 reverse transcriptase.
    Althaus IW; Chou KC; Lemay RJ; Franks KM; Deibel MR; Kezdy FJ; Resnick L; Busso ME; So AG; Downey KM; Romero DL; Thomas RC; Aristoff PA; Tarpley WG; Reusser F
    Biochem Pharmacol; 1996 Mar; 51(6):743-50. PubMed ID: 8602869
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and antiviral activity of 4-benzyl pyridinone derivatives as potent and selective non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors.
    Dollé V; Nguyen CH; Legraverend M; Aubertin AM; Kirn A; Andreola ML; Ventura M; Tarrago-Litvak L; Bisagni E
    J Med Chem; 2000 Oct; 43(21):3949-62. PubMed ID: 11052800
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of human immunodeficiency virus 1 reverse transcriptase by 3'-azidothymidine triphosphate.
    Heidenreich O; Kruhøffer M; Grosse F; Eckstein F
    Eur J Biochem; 1990 Sep; 192(3):621-5. PubMed ID: 1698626
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A short-term clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. L-697,661 Working Group.
    Saag MS; Emini EA; Laskin OL; Douglas J; Lapidus WI; Schleif WA; Whitley RJ; Hildebrand C; Byrnes VW; Kappes JC
    N Engl J Med; 1993 Oct; 329(15):1065-72. PubMed ID: 7690462
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhanced binding of azidothymidine-resistant human immunodeficiency virus 1 reverse transcriptase to the 3'-azido-3'-deoxythymidine 5'-monophosphate-terminated primer.
    Canard B; Sarfati SR; Richardson CC
    J Biol Chem; 1998 Jun; 273(23):14596-604. PubMed ID: 9603976
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human immunodeficiency virus reverse transcriptase: steady-state and pre-steady-state kinetics of nucleotide incorporation.
    Reardon JE
    Biochemistry; 1992 May; 31(18):4473-9. PubMed ID: 1374638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.